| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 624.920 | 1.359.608 | 584.456 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | 624.929 | 1.360.565 | 587.296 | 1.018 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | - | 195.231 | 426.489 | 219.153 | 82.924 | 11.258 | 10.768 | 11.684 |
| Gross Profit/Loss - EUR | - | - | - | 429.698 | 934.076 | 368.143 | -81.906 | -11.258 | -10.768 | -11.684 |
| Net Profit/Loss - EUR | - | - | - | 423.448 | 848.602 | 310.574 | -81.907 | -11.258 | -10.768 | -11.684 |
| Employees | - | - | - | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Concorde Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 17 | 9.928 | 30.839 | 45.289 | 35.700 | 27.110 | 19.370 |
| Current Assets | - | - | - | 610.399 | 1.014.848 | 373.016 | 26.624 | 27.233 | 27.099 | 23.365 |
| Inventories | - | - | - | 124.324 | 68.285 | 10.226 | 5.081 | 5.097 | 5.082 | 5.053 |
| Receivables | - | - | - | 451.571 | 849.565 | 352.278 | 21.352 | 21.833 | 21.926 | 18.226 |
| Cash | - | - | - | 34.503 | 96.998 | 10.512 | 190 | 304 | 91 | 86 |
| Shareholders Funds | - | - | - | 423.491 | 853.304 | 315.213 | -77.370 | -88.868 | -99.367 | -110.496 |
| Social Capital | - | - | - | 43 | 1.264 | 1.240 | 1.213 | 1.217 | 1.213 | 1.206 |
| Debts | - | - | - | 186.924 | 171.928 | 88.846 | 149.319 | 151.809 | 153.576 | 153.230 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Concorde Medical Srl